All Videos Tagged bioinformatics (MedTech I.Q.) - MedTech I.Q.

Informatics: Personal Genome Computing: Breakthroughs, Risks and Opportunities

2009-09-02T07:04:51.488Z

ChurchillClub
February 02, 2009

"Technology breakthroughs are making DNA sequencing faster and cheaper than ever. In its top ten list of 2008 scientific breakthroughs that broke through with the potential for lasting impact, Scie...
"Technology breakthroughs are making DNA sequencing faster and cheaper than ever. In its top ten list of 2008 scientific breakthroughs that broke through with the potential for lasting impact, Science magazine included technology that has blown the doors off genome sequencing. In Nature magazines list of the top news stories of 2008, "Personal genomics goes mainstream" came in second. With the cost of DNA sequencing plummeting, the emergence of "molecular sequencing" platforms has forever changed the field of genetics.

A new paradigm appears on the horizon. Personal genome information will be used not just for health maintenance, disease diagnosis, and treatment, but will also be the foundation for lifestyle applications from shopping for food, to buying cosmetics, to assessing ones environment and making choices about fabrics, places - even friends.

This panel of Silicon Valley players and innovators of new business models examines the dynamic business and investment opportunities as well as the risks, global competition, regulatory and legal challenges, new individual contributor roles, and leading alliances emerging from Silicon Valley and beyond.

Silicon Valley changed the world as the driving force in the development of computers and the internet. Could we play a similar role in advancing a genome-based economy?". Panelists:

•Linda Avey, Founder, 23andMe.
•David Medina, HP Chief Technologist, Worldwide Health & Life Sciences
•Karoly Nikolich., Dievini Hopp Biotech Holding, CEO of Amnestix
•Andras Pellionisz, founder, International Hologenomics Society and HolGenTech
•Dietrich Stephan, founder, Navigenics, founder of Amnestix

Moderator:
•Phyllis Whiteley, Mohr-Davidow Ventures

Sponsor/Organizer:
•Gutenberg Communications: Suzanne Matick, Principal, Los Gatos Office

Churchill Club
Thursday January 22, 2009, Palo Alto, CA
www.churchillclub.org

Bioinformatics: Ethical/Policy Challenges of Advanced Genetic Screening

2009-09-02T06:54:38.550Z

Dr. Edward McCabe, Professor and Executive Chair of the UCLA Department of Pediatrics and Director of the UCLA Center for Society, the Individual and Genetics discusses the ethical and policy challenges facing the clinical application of genetic screening. Series: "Science Futures" [4/2003] [Public Affairs] [Science] [Show ID: 7052]

Informatics: Esther Dyson of EDVentures on Genetic Information: Extended Interview

2009-06-17T20:19:59.123Z

Esther Dyson, a catalyst-investor in numerous technologies, believes that knowing more about our own genetic makeup allows us to make better decisions about our lives and our health. That in turn will lead to a raft of new companies and products that will provide us with better information and recommendations tailored to our unique genetic makeup and physical characteristics.

Esther Dyson is a long-time catalyst of start-ups in information technology in the U.S. and other markets, including Russia. Since selling her company, EDventure Holdings, to CNET Networks in 2004, she has taken on newer challenges in private aviation and space as well as in health care (as a director of 23andMe, a consumer genetics company). Her IT investments have included Flickr and del.icio.us (both sold to Yahoo!), and Medstory (sold to Microsoft), as well as Meetup Inc., Eventful.com, Boxbe and Voxiva. She is also an active investor in air and space, with holdings in Space Adventures and Zero-G Corporation, as well as XCOR Aerospace, Constellation Services International, Coastal Technologies Group, Dopplr.com, Airship Ventures and Icon Aircraft. She was recently honored with the Aenne Burda Award for Creative Leadership at the DLD Conference in Munich.

Informatics: IBM - Hartwell Center for Bioinformatics and Biotechnology at St. Jude Children's Research Hospital

2008-10-26T04:15:59.733Z

The Hartwell Center for Bioinformatics and Biotechnology at St. Jude Children's Research Hospital speeds clinical research time with a BladeCenter Linux cluster that shortens task processing time from days or weeks to just hours.

Informatics:Current Issues in Computational Biology and Bioinformatics

2008-10-24T23:33:41.301Z

Google Tech Talks, August 26, 2008

A brief overview of bioinformatics computational problem landscape followed by a detailed look at one of
the areas: multiple perturbation analysis of cells using reverse engineering principles.

Speaker: Gary Bader
Gary is Assistant Professor at the Terrence Donnelly Centre for Cellular and Biomolecular Research (CCBR) at the University of Toronto. http://baderlab.org/